| Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle RM Schiffelers, A Ansari, J Xu, Q Zhou, Q Tang, G Storm, G Molema, ... Nucleic acids research 32 (19), e149-e149, 2004 | 1186 | 2004 |
| Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers TB Wyman, F Nicol, O Zelphati, PV Scaria, C Plank, FC Szoka Biochemistry 36 (10), 3008-3017, 1997 | 667 | 1997 |
| Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis B Kim, Q Tang, PS Biswas, J Xu, RM Schiffelers, FY Xie, AM Ansari, ... The American journal of pathology 165 (6), 2177-2185, 2004 | 364 | 2004 |
| Binding of ethidium bromide to a DNA triple helix. Evidence for intercalation. PV Scaria, RH Shafer Journal of Biological Chemistry 266 (9), 5417-5423, 1991 | 289 | 1991 |
| Highly branched HK peptides are effective carriers of siRNA Q Leng, P Scaria, J Zhu, N Ambulos, P Campbell, AJ Mixson The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2005 | 186 | 2005 |
| Effects of treatment with small interfering RNA on joint inflammation in mice with collagen‐induced arthritis RM Schiffelers, J Xu, G Storm, MC Woodle, PV Scaria Arthritis & Rheumatism 52 (4), 1314-1318, 2005 | 185 | 2005 |
| Peptide-based antifungal therapies against emerging infections A Matejuk, Q Leng, MD Begum, MC Woodle, P Scaria, ST Chou, ... Drugs of the Future 35 (3), 197, 2010 | 180 | 2010 |
| Quadruplex structure of d (G3T4G3) stabilized by K+ or Na+ is an asymmetric hairpin dimer. PV Scaria, SJ Shire, RH Shafer Proceedings of the National Academy of Sciences 89 (21), 10336-10340, 1992 | 140 | 1992 |
| Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma N Babae, M Bourajjaj, Y Liu, JR Van Beijnum, F Cerisoli, PV Scaria, ... Oncotarget 5 (16), 6687, 2014 | 130 | 2014 |
| Pharmaceutical prospects for RNA interference RM Schiffelers, MC Woodle, P Scaria Pharmaceutical research 21, 1-7, 2004 | 98 | 2004 |
| Structure and function correlation in histone H2A peptide-mediated gene transfer D Balicki, CD Putnam, PV Scaria, E Beutler Proceedings of the National Academy of Sciences 99 (11), 7467-7471, 2002 | 93 | 2002 |
| Sterically stabilized polyplex: ligand-mediated activity MC Woodle, P Scaria, S Ganesh, K Subramanian, R Titmas, C Cheng, ... Journal of controlled release 74 (1-3), 309-311, 2001 | 84 | 2001 |
| Cationic liposomes and nucleic acids MC Woodle, P Scaria Current opinion in colloid & interface science 6 (1), 78-84, 2001 | 75 | 2001 |
| Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice SA Healy, C Anderson, BJ Swihart, A Mwakingwe, EE Gabriel, ... The Journal of clinical investigation 131 (7), 2021 | 62 | 2021 |
| Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts Q Leng, P Scaria, P Lu, MC Woodle, AJ Mixson Cancer gene therapy 15 (8), 485-495, 2008 | 62 | 2008 |
| Therapeutic methods for nucleic acid delivery vehicles P Lu, P Scaria, M Woodle, F Xie, J Xu, Q Tang US Patent App. 10/286,956, 2003 | 62 | 2003 |
| Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate AJ Radtke, CF Anderson, N Riteau, K Rausch, P Scaria, ER Kelnhofer, ... Scientific reports 7 (1), 40312, 2017 | 61 | 2017 |
| Calorimetric Analysis of Triple Helices Targeted to the d(G3A4G3)·d(C3T4C3) Duplex PV Scaria, RH Shafer Biochemistry 35 (33), 10985-10994, 1996 | 53 | 1996 |
| Polyethyleneimine (PEI) Mediated siRNA Gene Silencing in the Schistosoma mansoni Snail Host, Biomphalaria glabrata M Knight, A Miller, Y Liu, P Scaria, M Woodle, W Ittiprasert PLoS neglected tropical diseases 5 (7), e1212, 2011 | 52 | 2011 |
| Transporting silence: design of carriers for siRNA to angiogenic endothelium RM Schiffelers, AJ Mixson, AM Ansari, MHAM Fens, Q Tang, Q Zhou, J Xu, ... Journal of controlled release 109 (1-3), 5-14, 2005 | 51 | 2005 |
